TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
St1 Biokraft AB
Closing information (x1000 SEK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
445,830
|
366,709
|
393,821 |
Financial expenses |
115,841
|
58,989
|
62,720 |
Earnings before taxes |
-172,356
|
-95,369
|
-45,486 |
EBITDA |
22,394
|
18,786
|
89,318 |
Total assets |
1,961,619
|
1,874,133
|
1,653,157 |
Current assets |
442,937
|
649,377
|
552,972 |
Current liabilities |
351,480
|
257,578
|
221,652 |
Equity capital |
579,927
|
742,845
|
506,626 |
- share capital |
87,158
![]() |
87,158
|
61,067 |
Employees (average) |
115
|
105
|
109 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
29.6%
|
39.6%
|
30.6% |
Turnover per employee |
3,877
|
3,492
|
3,613 |
Profit as a percentage of turnover |
-38.7%
|
-26.0%
|
-11.5% |
Return on assets (ROA) |
-2.9%
|
-1.9%
|
1.0% |
Current ratio |
126.0%
|
252.1%
|
249.5% |
Return on equity (ROE) |
-29.7%
|
-12.8%
|
-9.0% |
Change turnover |
79,121
|
-27,112
|
55,435 |
Change turnover % |
22%
|
-7%
|
16% |
Chg. No. of employees |
10
|
-4
|
30 |
Chg. No. of employees % |
10%
|
-4%
|
38% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.